NasdaqCM - Delayed Quote USD

Sanara MedTech Inc. (SMTI)

32.35 +0.14 (+0.43%)
At close: April 26 at 4:00 PM EDT
32.35 0.00 (0.00%)
After hours: April 26 at 4:20 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
64,989.84
64,989.84
45,842.85
24,143.92
15,586.98
Cost of Revenue
7,852.69
7,852.69
6,360.85
2,311.22
1,616.63
Gross Profit
57,137.16
57,137.16
39,481.99
21,832.70
13,970.35
Operating Expense
64,802.20
64,802.20
51,714.43
29,208.86
19,004.96
Operating Income
-7,665.05
-7,665.05
-12,232.43
-7,376.16
-5,034.61
Net Non Operating Interest Income Expense
-475.78
-475.78
--
-0.71
-11.53
Other Income Expense
3,700.93
3,700.93
-1,704.69
-616.93
601.00
Pretax Income
-4,439.90
-4,439.90
-13,937.12
-7,993.80
-4,445.15
Tax Provision
--
--
-5,844.80
--
--
Net Income Common Stockholders
-4,303.20
-4,303.20
-7,937.50
-7,921.91
-4,356.44
Diluted NI Available to Com Stockholders
-4,303.20
-4,303.20
-7,937.50
-7,921.91
-4,356.44
Basic EPS
-0.52
--
-1.00
-1.08
-0.76
Diluted EPS
-0.52
--
-1.00
-1.08
-0.76
Basic Average Shares
8,278.95
--
7,906.79
7,341.58
5,734.54
Diluted Average Shares
8,278.95
--
7,906.79
7,341.58
5,734.54
Total Operating Income as Reported
-4,215.15
-4,215.15
-12,517.18
-7,376.16
-5,034.61
Total Expenses
72,654.89
72,654.89
58,075.28
31,520.08
20,621.59
Net Income from Continuing & Discontinued Operation
-4,303.20
-4,303.20
-7,937.50
-7,921.91
-4,356.44
Normalized Income
-8,004.13
-8,004.13
-6,890.70
-7,921.91
-4,942.61
Interest Expense
475.78
475.78
--
0.71
11.53
Net Interest Income
-475.78
-475.78
--
-0.71
-11.53
EBIT
-3,964.12
-3,964.12
-13,937.12
-7,993.08
-4,433.62
EBITDA
-289.09
-289.09
-11,566.06
-7,396.11
-4,142.25
Reconciled Cost of Revenue
7,852.69
7,852.69
6,360.85
2,311.22
1,616.63
Reconciled Depreciation
3,675.03
3,675.03
2,371.07
596.98
291.37
Net Income from Continuing Operation Net Minority Interest
-4,303.20
-4,303.20
-7,937.50
-7,921.91
-4,356.44
Total Unusual Items Excluding Goodwill
3,700.93
3,700.93
-1,325.06
--
586.17
Total Unusual Items
3,700.93
3,700.93
-1,325.06
--
586.17
Normalized EBITDA
-3,990.02
-3,990.02
-10,241.00
-7,396.11
-4,728.42
Tax Rate for Calcs
--
--
0.00
--
--
Tax Effect of Unusual Items
--
--
-278.26
--
--
12/31/2020 - 4/7/1994

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

ECIA Encision Inc.
0.4400
0.00%
 
POCI Precision Optics Corporation, Inc.
5.60
-1.06%
 
NXGL NEXGEL, Inc.
2.2100
-5.15%
 
PDEX Pro-Dex, Inc.
18.68
+1.19%
 
ANIK Anika Therapeutics, Inc.
25.57
-0.04%
 
INFU InfuSystem Holdings, Inc.
8.12
+6.70%
 
BLFS BioLife Solutions, Inc.
17.53
+3.97%
 
UTMD Utah Medical Products, Inc.
65.92
-0.56%
 
LMAT LeMaitre Vascular, Inc.
65.46
+3.92%
 
DIM.PA Sartorius Stedim Biotech S.A.
208.30
+2.41%